吉林敖东品牌怎么样 申请店铺
吉林敖东药业集团股份有限公司的前身是1957年成立的国营延边敦化鹿场,于1981年建立敖东制药厂,1993年3月经省体改委批准改制为吉林敖东药业集团股份有限公司,1996年10月28日在深交所挂牌上市。公司现控股7家从事现代中药、生物化学药和植物化学药的专业制药子公司,1家医药销售子公司,2家医药配套子公司及参股广发证券、塔东矿业,拥有种植、养殖基地,建立了“公司+标准化基地+特许农户”的产业链经营模式,逐步发展成为“资源共享、管理科学、持续发展”的集医药业、证券业、采矿业、公路建设业为一体的控股型集团公司。
公司注册地址为吉林省敦化市敖东大街2158号,公司总股本57,335.797万股,法人代表为李秀林。
截止2009年末,公司总资产为716,221万元,净资产为656,037万元,资产负债率为8.40%。2009年度实现销售收入102,552万元,利润总额141,313万元,净利润136,649万元。
公司1998年被国家经贸委认定为国家级技术中心,成为企业技术进步和技术创新的主要技术依托。2001年12月11日国家人事部批准设立博士后工作站,在“十五”期间吉林敖东国家级技术中心建设成为新技术研究开发中心和产学研合作交流中心以及技术决策咨询中心;2002年,公司被农业部等九部委批准为农业产业化国家重点龙头企业;2003年9月,被国家科技部评为“火炬计划优秀高新技术企业”;2002年1月被评为中药现代化科技产业基地示范企业;2007年4月获得全国五一劳动奖状,再次被国家农业部等九部委评为农业产业化重点龙头企业;2008年1月被评为吉林省企业信息化示范单位,连续多年获吉林省A级纳税企业,AAA级银行信用等级,守合同重信用单位等荣誉;2009年12月荣获第十六届国家级一等企业管理现代化创新成果。
公司经过了几十年的发展,形成了独具特色的品牌优势,“敖东及图”商标1999年被国家工商总局认定为驰名保护,连续六年成为“中国500最具价值品牌”。公司主导产品“安神补脑液”、“血府逐瘀口服液”、“利脑心胶囊”、“心脑舒通胶囊”等多年来一直保持省优、部优和中国中药名牌产品称号,“小牛脾提取物注射液”、“注射用核糖核酸Ⅱ”、“鹿胎颗粒”、“少腹逐瘀颗粒”、“养血饮口服液”、“愈心痛胶囊”、“小儿柴桂口服液”等产品也以质量稳定、疗效确切受到市场好评,销量逐年增加,为公司持续发展奠定了坚实的基础。
公司将继续深入贯彻“加强生产精细管理、深化营销体制改革、调整产品研发方向、推进信息网络建设、完善经营目标考核、提升企业综合实力”的方针,为股东创造更大的价值,并兼顾消费者、员工、债权人、供应商等相关者的利益,为社会经济的发展做贡献。
The predecessor of Jilin Aodong Pharmaceutical Group Co., Ltd. is the state-owned Yanbian Dunhua deer farm established in 1957. Aodong pharmaceutical factory was established in 1981. In March 1993, it was approved by the provincial Commission for restructuring and reform to Jilin Aodong Pharmaceutical Group Co., Ltd. and listed on the Shenzhen Stock Exchange on October 28, 1996. The company now holds 7 professional pharmaceutical subsidiaries engaged in modern Chinese medicine, biochemical medicine and phytochemical medicine, 1 pharmaceutical sales subsidiary, 2 pharmaceutical supporting subsidiaries, and shares in GF Securities and Tadong mining. It owns planting and breeding bases, and has established the industrial chain management mode of "company + standardized base + franchised farmers", which has gradually developed into "resource sharing and management science" "Sustainable development" is a holding group company integrating medical and pharmaceutical industry, securities industry, mining industry and highway construction industry. The registered address of the company is 2158 Aodong street, Dunhua City, Jilin Province. The total share capital of the company is 573.35797 million shares, and the legal representative is Li Xiulin. By the end of 2009, the total assets of the company were 7162.21 million yuan, the net assets were 6560.37 million yuan, and the asset liability ratio was 8.40%. In 2009, the company realized sales revenue of 1025.52 million yuan, total profit of 1413.13 million yuan and net profit of 1366.49 million yuan. In 1998, the company was recognized as a national technology center by the State Economic and Trade Commission, and became the main technical support for technological progress and innovation of enterprises. On December 11, 2001, the Ministry of Human Resources approved the establishment of a postdoctoral workstation. During the Tenth Five Year Plan period, Jilin Aodong national technology center was built into a new technology research and development center, an industry university research cooperation exchange center and a technology decision consultation center. In 2002, the company was approved as a national key leading enterprise of agricultural industrialization by the Ministry of agriculture and other nine ministries and commissions. In September 2003, it was appraised by the Ministry of science and technology of the people's Republic of China It is an excellent high-tech enterprise of torch plan; in January 2002, it was rated as a demonstration enterprise of modern science and technology industrial base of traditional Chinese medicine; in April 2007, it was awarded the National May 1st Labor Medal, and was once again rated as a key leading enterprise of agricultural industrialization by nine ministries and commissions including the Ministry of agriculture; in January 2008, it was rated as an enterprise informatization demonstration unit of Jilin Province, A-level tax paying enterprise and AAA level silver of Jilin Province for many consecutive years In December 2009, it won the 16th national first-class enterprise management modernization innovation achievement. After decades of development, the company has formed a unique brand advantage, "Aodong Hetu" trademark was recognized as well-known protection by the State Administration of industry and Commerce in 1999, and has become "China's 500 most valuable brand" for six consecutive years. The company's leading products, such as "Anshen Bunao liquid", "Xuefu Zhuyu oral liquid", "linanxin capsule", "Xinnaoshutong Capsule", have been keeping the titles of provincial and ministerial excellent and famous brand products of Chinese traditional medicine for many years, "calf spleen extract injection", "ribonucleic acid II for injection", "deer embryo Granule", "Shaofu Zhuyu Granule", "yangxueyin oral liquid", "Yuxin oral liquid" Tongjiaonang, xiaoerchaigui oral liquid and other products are also praised by the market for their stable quality and effective effect. The sales volume has increased year by year, laying a solid foundation for the company's sustainable development. The company will continue to implement the policy of "strengthening the fine management of production, deepening the reform of marketing system, adjusting the direction of product research and development, promoting the construction of information network, improving the assessment of business objectives, and enhancing the comprehensive strength of the enterprise", create greater value for shareholders, take into account the interests of consumers, employees, creditors, suppliers and other stakeholders, and contribute to the development of social economy.
本文链接: https://brand.waitui.com/6143e8f51.html 联系电话:0433-6238973